Current Studies
A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD)
INTERVIEWS IN ADULTS WITH MAJOR DEPRESSIVE DISORDER AND SLEEP DISTURBANCE
This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia
Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation (Vibrant)
GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease
- For participants ages 18 to 45 experiencing Postpartum Depression.
- Gave birth within the last 6 months.
- Depression symptoms began at some point between the third trimester and 4 weeks after delivery.
- Willing to consider alternatives to breastfeeding while taking study medication (3 weeks).
INTERVIEWS IN ADULTS WITH MAJOR DEPRESSIVE DISORDER AND SLEEP DISTURBANCE
- Ages 18 to 74
- Currently taking a medication for depression
- Currently experiencing depression with sleep disturbance
- Have access to a PC computer and internet and able to complete a 90 minute interview in a private setting
This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia
- For participants ages 18 to 50
- Diagnosis of schizophrenia.
- Symptoms and treatments have been generally stable for the last 3 months.
- Have a study partner who can participate in the study also.
Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation (Vibrant)
- For participants ages 22 and older
- On average have between 1 and 3 spontaneous (with out laxative) bowel movements a week.
GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease
- For participants ages 55 to 80
- Have Mild to Moderate Alzheimer's Disease
- Have a Study Partner or Caregiver who can attend study visit